Physitrack (Q1 Preview): Focus on margin resilience and growth inflection - Redeye

Redeye shares its preview of Physitrack’s Q1 results, due on 23 April. While recent newsflow regarding new agreements is encouraging, the timing suggests a limited impact on the Q1 figures. We expect the report's highlights to be continued margin expansion and a return to growth for Lifecare ARR.

Länk till analysen i sin helhet: https://www.redeye.se/research/1159202/physitrack-q1-preview-focus-on-margin-resilience-and-growth-inflection?utm_source=finwire&utm_medium=RSS